Cargando…
Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments
Vitiligo is an auto-immune disease, causing depigmentation of skin in 0.2-1.8% of global population. Topical corticosteroids and calcineurin inhibitors are the only treatments with firm evidence of optimal effectiveness with considerable side effects. Phototherapies might not induce serious side eff...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Royan Institute
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105300/ https://www.ncbi.nlm.nih.gov/pubmed/37038694 http://dx.doi.org/10.22074/CELLJ.2023.557550.1067 |